Introduction
Arachidonic acid (AA) is not only an abundant component of cell membranes (incorporated into phospholipids), but also is the precursor of prostanoids and all endocannabinoids (ECs). Thus, AA is of primary importance in neuro-and immunomodulation, energy metabolism, as well as the cardiovascular system [1] [2] [3] .
The pool of free AA, which may vary in different tissues and between individuals, is known to be regulated by phospholipase A2 (PLA2) and 2-arachidonoyl glycerol (2-AG)
hydrolysis. Recently, the levels of 2-AG and AA were shown to inversely correlate with the free AA generated upon hydrolysis of 2-AG which was shown to act as precursor for eicosanoid biosynthesis [4] . Prostanoids are a family of lipid mediators that play key roles in both inflammatory and neuropsychiatric processes. They are produced upon the enzymatic oxygenation of AA by cyclooxygenase-2 (COX-2) resulting in e.g. the production of prostaglandin E 2 (PGE 2 ) and thromboxane B 2 (THB B 2 ) [5] . Attention has recently been paid to the fact that like AA, ECs containing an arachidonoyl moiety are good substrates of COX-2, leading to the formation of similar prostanoid derivatives (e.g., prostaglandin E 2 ethanolamide (PGE 2 EA)) [6] .
The endocannabinoid system is involved in different physiological and pathophysiological processes that occur mainly in the central nervous system (CNS) and immune system, but also exerts regulatory effects on metabolic processes and vascular tone [7] . ECs are produced "on demand" in the body from precursor phospholipids containing arachidonyl moieties derived from arachidonic acid including N-acylphosphatidylethanolamine (NAPE) and diacylglycerol (DAG) [8, 9] . These bioactive lipids are not stored in vesicles, but are transported across the plasma membrane by as yet poorly understood mechanisms [10] . The distribution of ECs between tissues and plasma is not equal and a correlation between brain and plasma levels cannot be drawn, unless experimentally shown. By definition, ECs interact with both central (CB 1 ) and peripheral (CB 2 ) G protein-coupled cannabinoid receptors and act as partial or full agonists [9] . The most important and best studied ECs are anandamide (AEA) and 2-arachidonoyl glycerol (2-AG), which can be found in numerous tissues [9, 11] . In addition to the classical ECs, virodhamine (VIR), noladin ether (NE) and N-arachidonoyl dopamine (NADA) have been proposed to act as ECs [12] . However, only limited information is available about the quantifiable amounts of these minor ECs in plasma and tissues. Another class of related compounds are amino acid conjugates (e.g., N-arachidonoyl-gamma-aminobutyric acid (A-GABA), Narachidonoyl-glycine (A-GLY) and N-arachidonoyl-serine (A-SER)), which have also been proposed to exert physiological effects [13, 14] . Furthermore, N-acylethanolamines other than AEA, which exhibit distinct saturated or unsaturated fatty acids and show no (or little) direct effect on CB receptors (i.e., linoleoyl ethanolamide (LEA), palmitoyl ethanolamide (PEA), oleoyl ethanolamide (OEA), stearoyl ethanolamide (SEA)), have been shown to act as ECs entourage molecules, possibly acting in concert with ECs [15] [16] [17] [18] . Yet another important class of signaling lipids involves the steroids, which appear to functionally interlink the different AA lipid signaling networks, including the endocannabinoid system [19, 20] . Steroids (glucocorticoids and mineralocorticoids) are involved in numerous physiological processes, including immunomodulation [21] . They are generated from cholesterol in the adrenal glands or the gonads, but some can also be formed in the CNS (neurosteroids) [22, 23] .
LC-MS/MS is a useful method for the quantitative analysis of lipophilic and apolar metabolites because it allows short analysis time, complete automation, minimal sample preparation (no derivatization), and it is applicable to analytes with a broad range of molecular masses and polarities. It has been widely used for the analysis of ECs and similar lipids [24] [25] [26] [27] [28] . However, it has only recently been used for the analysis of steroids [29] [30] [31] . 
Materials and methods

Materials
Analytical and internal standards were purchased from Cayman Chemical, Tallinn 
Silanization of glass and plastic ware
To prevent absorption of lipids, glass tubes and plastic tips were immersed for 2-5 min on AQUASIL solution (20 mL in 1L of distilled water), rinsed with methanol and dried at room temperature prior to the analysis.
Standard solutions
In order to prepare the standard mixtures used as calibrators (calibration solutions) and internal standards (IS), solutions of 1.0 and 0.01 mg/mL of analytical and labeled standards were prepared in EtOH. These solutions were kept at -80°C and the stability of the analytes was monitored throughout the analysis. In order to achieve these analytical concentrations in a final volume of 100 µL, 10 µL of a tenfold concentration of the calibrator and IS mixture were used (10 µL of 2-AG-d 5 500 ng/mL solution, brought upto a final volume of 100 µL to achieve a concentration of 50 ng/mL). The calibration curve used for the analysis of plasma samples was built to include 6-9 calibration points.
Plasma samples
For the validation, pooled plasma purchased from the blood bank in Bern (Blutspendezentrum SRK Bern) was used. Aliquots of 0.5 mL were used to construct calibration curves and prepare quality control samples (QC). QC (n=6) were prepared to evaluate intra-and inter-day levels of precision (non-spiked samples (QC 0 )), and to evaluate the efficiency of analyte recoveries at low (QC 4 : level 4) and high (QC 7 : level 7)
concentrations (see Table 4 )). QC were prepared and stored at -80°C until analysis. QC used for the analysis of inter-day precision, recovery and stability were run over 4 different days by two different analysts within a period of 4 weeks. The plasma used for preparing QC for intra-day analysis came from a different pool from the plasma used for preparing QC used for the inter-day evaluation. QC samples were prepared as follows: hours after blood collection by centrifuging at 1,300 g for 10 min at 4°C. Blood samples were kept on ice until plasma generation. Plasma (ca. 5mL) was stored at -80°C prior the analysis.
Sample preparation
Plasma was thawed inside the refrigerator at 6°C for 3-4 hours prior the analysis (under our working conditions, 3 hours is the minimal time required for total thawing). In a 2 mL 
Chromatographic and mass spectrometric conditions 2.6.1. Equipment
Analyses were conducted on an LC-MS/MS system consisting of an API 4000 QTrap mass spectrometer equipped with a TurboIonSpray probe (AB Sciex Concord, Ontario, Canada) connected to a Shimadzu UFLC (Shimadzu Corporation, Kyoto, Japan). Data acquisition and analyses were performed using Analyst software version 1.5 (AB Sciex Concord, Ontario, Canada).
Chromatographic conditions
Analytical LC separations were performed on a Reprosil-PUR C18 column (3 µm particle size; 2×50 mm, Dr. A. Maisch, High Performance LC-GMBH, Ammerbuch, Germany) with a flow rate of 0.35 mL/min and oven temperature of 40°C using a gradient of CH 3 OH containing 2 mM ammonium acetate (eluent B) and water containing 2 mM ammonium acetate and 0.1% formic acid (eluent A). The gradient was as follows:
15% eluent B for 0.5 min; 15-70% B from 0.5 -3.5 min; 70-99% B from 3.5-8.0 min and held at 99% from 8.0-11.0. From 11.0-11.5 min, the column was re-equilibrated to 15% B and conditioned from 11.5-13 min at 15% B. The autosampler was cooled at 4°C.
MS/MS detection
The TurboIon Spray interface was operated in negative ionization mode for the analysis of AA, PGE 2 and THB 2 and in positive mode for the analysis of AEA, 2-AG, A-GABA, A-GLY, ALDO, ANDRO, A-SER, COR, DHEA, LEA, NADA, NE, OEA, PEA, PGE 2 -EA, PROG, SEA, TEST, THDOC, THP and VIR. The parameters of the source using nitrogen as a curtain gas were as follows: capillary ion spray voltage +4500 V in positive and -4250 V in negative modes, respectively; temperature 600 °C; curtain gas 25 psi, GS1 50 psi and GS2 50 psi. The entrance potential and collision cell exit potentials were both set to 10 V. The analytes were measured in the multiple reaction monitoring mode (MRM). Two MRM, one quantifier (Q) and one qualifier (q) were considered in the analysis. The MRM parameters (retention time, precursor ion/ product ion, declustering potential, collision energy) for the quantifier MRM used in the survey and the respective internal standard (IS) are presented in Table 1 . For the negative ionization mode, a dwell time of 50 ms was used for all MRM transitions, while for the positive ionization mode, the schedule MRM function was applied (target scan time of 0.8 sec and MRM detection window of 100 sec). Data were acquired and processed using Analyst software.
Validation
The method was validated using external calibrations spiking calibration solutions (see section 2.3) into plasma and processing following section 2.5 on 6 consecutive days (n=6). Quality control samples (n=6 of QC 0 , QC 4 and QC 7 ) were measured to fully validate the method (see section 2.4). The results were analyzed based on the peak area ratio between the analyte and IS. The IS used for each analyte measured are listed in Table 1 . The full validation of the method was performed only for the analytes that could be detected in human plasma (AA, PGE 2, THB B 2 , AEA, 2-AG, LEA, NE, OEA, PEA, SEA, ALDO, COR, DHEA, PROG and TEST). However, MRM, chromatographic conditions, LOD and low limit of quantification (LLOQ) of the analytes evaluated (except for VIR, which could not be recovered after spiking) were determined and are presented in Tables 1 and 2 . Calibration curves were generated by subtracting the endogenous amount of an analyte from the spiked amount (blank subtraction). The results of the analysis allowed the determination of LOD, LLOQ, accuracy, linearity, precision and stability. The effect of the matrix on the analytes will be also discussed.
Additionally, the levels of the compounds investigated were analyzed in 32 healthy male volunteers (see section 2.4).
Results
LOD/LLOQ
Due to the endogenous presence of the validated analytes in plasma, the instrumental LOD (signal-to-noise ratio 3) of standards was used ( Table 2 ). The LLOQ was obtained from spiked plasma as the concentration at which the signal-to-noise ratio was 10 and
showed positive values after blank subtraction (the area ratio of a spiked analyte in plasma subtracting the area ratio of the analyte in blank plasma). For the analytes not detected in plasma, the LOD and LLOQ (Table 2) were determined as explained above for the LLOQ of the endogenous substances (signal-to-noise ratio 3/10 for the LOD/LLOQ).
Accuracy and linearity
The accuracy (percentage ratio of the measured concentration and theoretical concentration) was determined at three concentrations (see Table 3 ). Samples were prepared by spiking the different calibration solutions together with the IS prior the addition of plasma (in a similar way as was used for the preparation of the calibration curves) and subsequent processing as described in section 2.5. After subtraction of the blank, the accuracy was determined. Quantification was performed using linear regression from calibration curves (ratio of peak area analyte/ peak area IS vs. analyte concentration) using 6-9 calibration points (see section 2.3). For all the analytes validated, the concentration range displayed directly proportional results (n=3) indicating that the method is linear. In Table 3 , the results of accuracy and linearity are summarized.
Precision, stability and recovery
The precision (standard deviation) of the method was determined using quality control samples QC (see section 2.4) and the results are summarized in Table 4 . The low intraday variability reflects the high performance of the method. All analytes show variation coefficients (CV) below 15%, except for AEA (20%). The inter-day analyses performed at three different concentrations (QC 0 , QC 4 and QC 7 (see section 2.4)) not only helped to establish the precision of the method, but also the stability (within 1 month). The highest variability is observed in QC 4 . This could be explained by the fact that the amounts of analytes spiked are low as compared to the endogenous levels of the analytes (the variability is less noticeable when spiking samples with higher concentrations of analytes, such as QC 7 ). This can be better appreciated when comparing the concentration spiked in QC 4 (Table 4) with the values reported in Table 5 (i.e., dynamic range and average of the analytical concentration obtained from the analysis of 32 plasma samples from healthy male volunteers (see section 2.4).
Considering the complexity of the plasma as a matrix, the results obtained for precision are acceptable (see Table 4 ) and show that the samples are stable under the experimental conditions used here. The recovery, calculated at two concentrations (QC 4 and QC 7 ), is within a conventional range of 70-130% (see Table 4 ). Recoveries were calculated after subtraction of blanks (average values of QC 0 ) of spiked QC samples (average values of QC 4 and QC 7 ). Interestingly, a significant difference existed between the average values of intra-day and inter-day analyses for 2-AG and TEST (see Table   4 ). As explained in section 2.3 (plasma samples), two different pool of plasma were used for the respective analyses.
Matrix effect
The assessment of the combined effect of the sample matrix and variable recoveries can be determined when evaluating the variability of the slopes (Table 3) . Low variability (CV %) indicates that the precision and accuracy of the method are not affected by the matrix or by the workup. Additionally, to evaluate the matrix effect, absolute area values from calibration curves were used. Data obtained from calibrators spiked into solvent and processed (without matrix) and calibrators spiked in plasma (with matrix) were evaluated. We selected two subsequent arbitrary points inside the calibration curve and subtracted the area values to calculate a delta area. In theory, the delta area should be similar if a matrix effect does not exist. This is the case for most of the analytes (ALDO, COR, DHEA, OEA, PEA, PROG and TEST). However, the delta area is lower for AA, NE, PGE 2 and THB B 2 , and higher for AEA, 2-AG and LEA, from which we conclude that a matrix effect for these analytes exists.
Application of the method
The levels of AA, AEA, 2-AG, ALDO, COR, DHEA, LEA, NE, OEA, PEA, PGE 2 , PROG, SEA, TEST, and THB B 2 in human plasma were analyzed in 32 healthy male volunteers (A-GABA, A-GLY, ANDRO , A-SER, NADA, PGE 2 EA, THP, and THDOC were not detected). Mean plasma concentrations are reported in Table 5 together with their respective mean analytical concentrations. Additionally, values previously described in literature are also reported.
Discussion
In an earlier study, we reported the results of an analysis of AA, 2-AG, AEA, OEA, PEA and PGE 2 in fetal bovine sera (FBS) using a quantitative GC-MS method [11] . The extraction procedure used for FBS analysis was the starting point for the current LC-MS/MS method validation in human adult plasma. The Folch extraction (as used in GC-MS analysis of FBS) followed by SPE clean up did not allow the efficient recovery of PEA and SEA in plasma samples of humans or rodents. Therefore, we precipitated plasma proteins using ACN or cold acetone, as previously reported [26, 27, 32] .
However, the use of cold acetone led to lower recoveries of the steroids measured (data not shown). Consequently, we selected ACN precipitation, followed by SPE clean up, could not be analyzed in this mode [24, [36] [37] [38] . Only one publication measured AA in positive mode (using a Micromass Quatro Micro spectrometer from Waters) [39] , but these results could not be reproduced using our instrument. Nevertheless, by performing two subsequent injections (first in negative and then in positive mode), inserting blank runs in between, we were able to quantitate all compounds.
With respect to the chromatography (see Figure 2 and supplementary Figure 1 ), all the analytes appeared as single peaks except for 2-AG (and its isomer 1-AG), 2-AG-d 5 , THB B 2 , and DHEA, which showed two peaks. In these cases, the two peaks were integrated together for their analysis. Figure 2 shows chromatograms of the compounds validated with the presented method (standards and plasma).
To assess the reliability of the method, we compared the values obtained from healthy male volunteers with similar results previously reported in literature (see Table 5 ). In some cases, it was not possible to find information about the levels of the analytes studied only in males and, therefore, levels for both males and females or only females are presented in Table 5 . In the case of LEA, no information could be found with regard to endogenous levels in human plasma, although we estimate that it is between 0.5-23 pmol/mL, according to information stated elsewhere [45] .
NE was originally isolated from pig brain and described as an endocannabinoid in 2001 [46] . Subsequently, it was reported only once more from rat brains and peripheral tissues [47] . NE has, however, never been reported in human plasma. In our study, we could detect NE in human plasma (data not shown). This finding requires further validation using high-resolution MS and additional experiments with blood samples from other mammals, which goes beyond the description of the method reported here.
Interestingly, two sensitive methods have been validated for the measurement of NE in human plasma, but neither of them reported endogenous levels [25, 27] . The LLOQ reported for NE by [25] (0.3 ng/mL) was lower than the LLOQ reported here (3.2 ng/mL). These studies used an API 4000 QTrap mass spectrometer in positive mode (as used here), but a different extraction procedure (single extraction with n-heptane/ ethyl acetate (1/1, v/v)), solvent composition for the LC (ACN and water both with 0.1% formic acid) and MRM transition (365/273). On the other hand, the method reported by Balvers et al. [27] , which uses a similar sample preparation method (ACN for extraction followed by a cleanup using SPE), but a different mass spectrometer (Thermo Finnigan The basal levels of PGE 2 and THB B 2 reported by Shinde et al. [24] are below our LOD.
It is known that prostanoid levels can increase in response to inflammation and pathophysiological conditions [48] and that the method can measure increased levels in plasma of PGE 2 and THB B 2. In 4 of the 32 samples analyzed, we observed THB B 2 at the LOD. The ALDO levels reported here with our method are higher that the levels reported in the literature, which compare radioimmunoassay (RIA) with LC-MS/MS (negative mode) [29, 30] . Both literature sources showed good correlations between the two methods of analysis (higher variation with RIA), however, only one of them provided information about the sample collection (samples were collected at midmorning from normotensive patients [29] ). The time at which the blood was collected and the condition of the subjects (fasting or not) are known to be critical in the analysis of steroids. The levels of aldosterone reported in the present study are in agreement with those reported by Hollenberg et al. [49] , who used RIA for the analysis of plasma samples. In that study, the samples were collected in the morning under fasting conditions that are similar to those used in our study.
Different studies have reported levels of THDOC and THP in human and rodent plasma using gas chromatography chemical ionization mass spectrometry (GC-MS) or radioimmunassays [50] [51] [52] [53] [54] [55] . Using our LC-MS/MS, we were unable to detect these analytes. In the case of THP, the LOD/LLOQ reported is the only reference to our knowledge that also includes analytical information about the method (ca. 1 pg/ 10 pg on column [50] ) is lower that our LOD/ LLOQ (160/ 400 pg on column (see Table 2 )).
Accordingly, only very low levels of THP were reported for plasma (77+20 pg/mL or 0.2+0.1 pmol/mL) in this study, leading us to question the physiological relevance of these amounts. With respect to the analysis of THDOC, most articles refer to Romeo et al. [56, 57] , in which a full method description is missing. Nevertheless, our LOD for THDOC (2.5 ng on column) was much higher than the one reported for THP (see Table   2 ). Furthermore, our method was not able to detect endogenous concentrations of A-GABA, A-GLY, A-SER, ANDRO, PGE 2 EA and NADA in human blood plasma. In agreement with our findings, two studies have tried to measure NADA and A-GLY in human plasma without success [25, 27] . So far, A-GABA and A-SER have only been identified in the mouse brain [58] .
Conclusions
In this study we validated an analytical method that enables researchers to Table 4 Analysis of quality control samples (QC): Intra-and inter-day precision and recovery analyses. 
